ClinicalTrials.Veeva

Menu

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Loma Linda University (LLU) logo

Loma Linda University (LLU)

Status

Enrolling

Conditions

Urgency-frequency Syndrome
Radiation Exposure
Urge Incontinence
Overactive Bladder

Treatments

Procedure: Conventional fluoroscopy
Procedure: Reduced radiation fluoroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT04527445
5200182

Details and patient eligibility

About

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

Full description

Patients scheduled for lead implantation during sacral neuromodulation in the operating room and consent will be included in this study. Placement of the lead in the operating room with fluoroscopy is the standard of care in this procedure. Fluoroscopy is performed with a C-arm and there are settings that change the radiation exposure. Patients scheduled to undergo lead placement will be randomized to: a) the investigational (reduced radiation with fluoroscopic settings) or b. the control (conventional fluoroscopy).

The surgeon can change fluoroscopy radiation exposure by changing C-arm settings from the reduced radiation to conventional fluoroscopic options. During the surgery, the surgeon may change the settings from reduced radiation (intervention) to conventional fluoroscopy (control) to safely place lead. The surgeon will use their judgment to optimally place lead and maintain safety during placement. Any deviation from randomization will be recorded.

The intervention arm is defined: Reduced radiation fluoroscopy technique is performed by the C-arm set at 1 pulses-per-second and reduction of current.

The control arm is defined: The standard of care in the conventional fluoroscopy, the C-arm is set at 30 pulses-per-second and the current set at the default.

Enrollment

44 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.

Exclusion criteria

  • neurogenic bladder, BMI >40, or peripheral neuropathy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

44 participants in 2 patient groups

Reduced Radiation Fluoroscopy
Experimental group
Description:
Reduced radiation fluoroscopy technique is performed by the C-arm set at 1 pulses-per-second and reduction of current.
Treatment:
Procedure: Reduced radiation fluoroscopy
Conventional Fluoroscopy
Active Comparator group
Description:
The standard of care is the conventional fluoroscopy, the C-arm is set at 30 pulses-per-second and the current set as the default.
Treatment:
Procedure: Conventional fluoroscopy

Trial contacts and locations

1

Loading...

Central trial contact

Forrest Jellison, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems